Zuckerberg’s tougher management style drove away Facebook execs, raised tension with Sandberg: report
Facebook CEO reportedly on war footing as criticism toward the company mounts
All Posts in "Markets"
Nordstrom’s profit takes a hit after credit-card-interest error
Nordstrom shares slumped 13% in Friday trading after the retailer took a 28-cents-per-share charge in the third quarter
Fortnite ‘V-Bucks’ more popular than cash on teens’ holiday wish lists
Young people are also lusting after Gucci and Apple products this holiday season.
If you’re worried about retiring at a stock-market top, this might help
Don’t get caught up in market timing
European stocks dragged lower by tech, Brexit concerns
ASML, AstraZeneca among the big decliners
Here’s why one chart watcher is ready to buy the bitcoin dip
If history is a guide, bitcoin at $5,500 could prove to be a bargain
Nvidia loses an AMD worth of market cap on worst day for stock in more than a decade
After Nvidia earnings show ‘crypto hangover,’ analysts slash price targets en masse
Oil prices suffer sixth weekly loss in a row
Natural gas tallies a weekly rise of nearly 15%
Natural gas will soon find more fuel to feed its rally
Prices for the fuel trade more than 30% higher month to date
Palladium futures tally a record high
Gold prices end higher, shaking off pressure from a stronger dollar
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
FDA rejects Regeneron’s blood cancer bispecific, delaying would-be challenger to J&J and Pfizer
Researchers receive $6.9M grant for tau-targeting drug with potential in Alzheimer’s and beyond
BridgeBio launches another offshoot with $300M and early genetic disease programs
PreciseDx picks up $20.7M to advance AI-based breast cancer risk assessment
Medtech VC investment held steady in Q2 with $3.3B of deal value: PitchBook
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role